Guggenheim 3rd Annual Healthy Altitudes CEO Summit Panel
Participation by Yujiro Hata, Chief Executive Officer, IDEAYA Biosciences, moderated by Dan Skovronsky, M.D. Ph.D. CSO, Eli Lilly with host Seamus Fernandez, Senior Managing Director and Global Biopharma Analyst, Guggenheim Securities
